Exparel for Postsurgical Pain Relief

Annual sales of Exparel are estimated at 39 million in the US. Pacira is planning to develop partnerships to market Exparel outside the US. Image courtesy of Pacira Pharmaceuticals.

cachename:Projectscachekey:rd287061489_1778510319_rd221744618_648160000_rd-1665407042_-1874280820_rd-488908060_-173330816_